Lobe Sciences Ltd.

LOBEF · OTC
Analyze with AI
8/31/2024
8/31/2023
8/31/2022
8/31/2021
Operating Activities
Net Income-$4,421-$4,707-$12,253-$22,821
Dep. & Amort.$85$44$10$6,547
Deferred Tax$0$0$999-$1,024
Stock-Based Comp.$272$302$621$922
Change in WC$1,329$1,516$848$185
Other Non-Cash$2,273$1,127$7,045$11,153
Operating Cash Flow-$462-$1,719-$2,731-$5,037
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0-$137
Inv. Purchases$0$0$0-$445
Inv. Sales/Matur.$0$0$1,743$0
Other Inv. Act.$0$0$0$1,649
Investing Cash Flow$0$0$1,743$1,067
Financing Activities
Debt Repay.$564$337$0-$88
Stock Issued$0$677$753$5,174
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0-$63$753-$168
Financing Cash Flow$564$950$753$4,918
Forex Effect-$4$1$0$23
Net Chg. in Cash$97-$767-$234$970
Supplemental Information
Beg. Cash$140$908$1,142$172
End Cash$238$140$908$1,142
Free Cash Flow-$462-$1,719-$2,731-$5,037
Lobe Sciences Ltd. (LOBEF) Financial Statements & Key Stats | AlphaPilot